NEK11 involved in cancer development

Researchers from BRIC and the European Institute of Oncology in Italy have demonstrated that NEK11 is an important component of the pathway enforcing the G2/M checkpoint, suggesting that genetic mutations in NEK11 may contribute to the development of human cancer. Read more...